Triple Therapy: Proven Results for Patients Living with HIV
The DHHS Guidelines recommend the use of a complete triple therapy based on a dual NRTI plus an INSTI for treatment initiation.1
Today's regimens offer sustained virologic efficacy, a high barrier to resistance, better tolerability and toxicity profiles, and relative ease of use.1
Download the complete infographic, HIV Treatment Then and Now: Strides in HIV Therapy, to see how best practices have changed along with development of new drug regimens.
PATIENT CONSIDERATIONS WHEN SELECTING A THERAPY
Potential side effects and regimen convenience are important factors when selecting a regimen.1 Consider a simplified regimen to help patients achieve their treatment goals.
According to the DHHS Guidelines, a regimen that includes all 3 components that is taken one time a day is easier for patients to use.1 Additionally, individualized care involves specific treatment considerations for a number of special patient populations and clinical scenarios. These include1:
- Results of pretreatment genotypic drug-resistance testing
- From acute infection to established
- High viral load and low CD4 count
- Initiating treatment or switching therapy
- Various health needs: pregnancy, coinfection, comorbidities, and interactions with concomitant medications
Consider a comprehensive therapy for patients living with HIV.